1. Home
  2. VIRC vs PMVP Comparison

VIRC vs PMVP Comparison

Compare VIRC & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$5.51

Market Cap

95.5M

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.17

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
PMVP
Founded
1950
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.5M
76.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
VIRC
PMVP
Price
$5.51
$1.17
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$7.30
N/A
AVG Volume (30 Days)
28.3K
414.3K
Earning Date
04-08-2026
05-08-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
0.16
N/A
Revenue
$199,652,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.77
N/A
P/E Ratio
$37.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.16
$0.91
52 Week High
$9.07
$1.88

Technical Indicators

Market Signals
Indicator
VIRC
PMVP
Relative Strength Index (RSI) 29.51 34.57
Support Level $5.16 $1.12
Resistance Level $6.40 $1.26
Average True Range (ATR) 0.16 0.07
MACD -0.03 -0.01
Stochastic Oscillator 6.76 2.27

Price Performance

Historical Comparison
VIRC
PMVP

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: